Theme | Topic/s |
Project Description
| Country | Institution | Link |
Health. | HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research.. | . | Israel. | Dead Sea Laboratories AHAVA. | Ver documento. |
Health. | HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research.. | . | Czech Republic. | Quinta - Analytica s.r.o.. | Ver documento. |
Health. | HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research.. | . | Ausria. | University of Vienna. Max F. Perutz Laboratories. | Ver documento. |
Health. | HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research.. | . | Germany. | 2007_03_13_Max-Planck Institute for molecular Genetics. | Ver documento. |
Health. | HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research.. | . | Lithuania. | Institute of Biotechnology, Vilniua. | Ver documento. |
Health. | HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research.. | . | Lithuania. | Profarma UAB, Vilnius. | Ver documento. |
Health. | HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research.. | . | Romania. | S.C. ROdax Impex S.R.L.. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | Romania. | M. Nasta Institute of Pneumology. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | United Kingdom. | Planer plc. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | France. | Université de Technologie de Compiègne. Laboratoire de Génie Enzymatique et Cellulaire. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | France. | Université de Technologie de Compiègne. Laboratoire de Génie Enzymatique et Cellulaire. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | Romania. | R&D National Institute for Microtechnology,. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | Lithuania. | Institute of Biotechnology, Vilnius. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | Lithuania. | Profarma UAB. | Ver documento. |
Health. | HEALTH-2007-1.2-5: Standardisation and improvement of pre-analytical procedures for in vitro diagnostics.. | . | Lithuania. | UAB Altechna. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Romania. | Centrul de Patologie Neuro-Musculara « Dr.Horia RADU ». | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Turkey. | Biotechnology SME "ITT – Advanced Medical Technologies",. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Egypt. | National Research Centre. Molecular Genetics & Enzymology. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Lithuania. | Vilnius University. Faculty of Natural Sci, Dept Botany & Genetics. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | United Kingdom. | IHG PHARMACO. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Egypt. | Cairo University Pediatric Hospitals. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Egypt. | Cairo University Pediatric Hospitals. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Egypt. | Cairo University Pediatric Hospitals, Diabetes Endocrine Metabolism Pediatric Unit. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Lithuania. | Institute of Biotechnology, Bilnius. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Lithuania. | Profarma UAB. | Ver documento. |
Health. | HEALTH-2007-1.2-6: High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation.. | . | Lithuania. | UAB Altechna. | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | Germany. | Fraunhofer Institute. | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | Czech Republic. | Charles University Prague. | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | United Kingdom. | Planer plc. | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | Egypt. | Egyptian National STI Network (ENSTINET). | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | España. | Sistemas Genómicos S.L.. | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | Belarus. | Institute of Biophysics and Cell Engineering, the National Academy of Sciences of Belarus (IBCENASB), Minsk. | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | Egypt. | Faculty of Medicine, Cairo University, Medical Biochemistry Department. | Ver documento. |
Health. | HEALTH-2007-1.4-6: Stem cell lines for cell-based therapies.. | . | Portugal. | ECBio- I&D em Biotecnologia. | Ver documento. |
Health. | HEALTH-2007-1.4-7: Development of stem cell culture conditions. | . | Germany. | Fraunhofer Institute. | Ver documento. |
Health. | HEALTH-2007-1.4-7: Development of stem cell culture conditions. | . | United Kingdom. | Planer plc. | Ver documento. |
Health. | HEALTH-2007-1.4-7: Development of stem cell culture conditions. | . | Italy. | Italian consortium. | Ver documento. |
Health. | HEALTH-2007-1.4-7: Development of stem cell culture conditions. | . | Italy. | Research Institute. | Ver documento. |
Health. | HEALTH-2007-1.4-7: Development of stem cell culture conditions. | . | Austria. | Medical University of Vienna, Dept. of Medical Biochemistry. | Ver documento. |
Health. | HEALTH-2007-1.4-7: Development of stem cell culture conditions. | . | Portugal. | ECBio- I&D em Biotecnologia. | Ver documento. |
Health. | HEALTH-2007-1.4-9: Adding value to EU stem cell therapy research: scientific. | . | Czech Republic. | Charles University Prague. | Ver documento. |
Health. | HEALTH-2007-1.4-9: Adding value to EU stem cell therapy research: scientific. | . | United Kingdom. | Planer plc. | Ver documento. |
Health. | HEALTH-2007-2.1.2-5: Multidisciplinary fundamental genomics and molecular biology approaches to study basic biological processes relevant to health and diseases.. | . | Germany. | 2007_03_13_Max-Planck Institute for molecular Genetics. | Ver documento. |
Health. | HEALTH-2007-2.1.2-5: Multidisciplinary fundamental genomics and molecular biology approaches to study basic biological processes relevant to health and diseases.. | . | Lithuania. | Vilnius University. Faculty of Natural Sci, Dept Botany & Genetics. | Ver documento. |
Health. | HEALTH-2007-2.1.2-5: Multidisciplinary fundamental genomics and molecular biology approaches to study basic biological processes relevant to health and diseases.. | . | Lithuania. | Institute for Biomedical Research. | Ver documento. |
Health. | HEALTH-2007-2.1.2-5: Multidisciplinary fundamental genomics and molecular biology approaches to study basic biological processes relevant to health and diseases.. | . | Lithuania. | Vilnius University, Institute of Experimental and Clinical Mrdicine. | Ver documento. |
Health. | HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders.. | . | Romania. | Centre for Personal Development. | Ver documento. |
Health. | HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders.. | . | Turkey. | Biotechnology SME "ITT – Advanced Medical Technologies",. | Ver documento. |
Health. | HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders.. | . | Albania. | Institute of Public Health. | Ver documento. |
Health. | HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders.. | . | Rumania. | “Carol Davila” University of Medicine and Pharmacy. Child and Adolescent Psychiatry. | Ver documento. |
Health. | HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders.. | . | Italy. | Research Institute. | Ver documento. |
Health. | HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders.. | . | Turkey. | Ankara University Faculty of Medicine, Department of Medical Genetics. | Ver documento. |
Health. | HEALTH-2007-2.2.1-10: Childhood and adolescent mental disorders.. | . | Greece. | NCP for FP7 "Health" & "Bio". | Ver documento. |
Health. | HEALTH-2007-2.2.1-7: Restorative approaches for therapy of neurodegenerative diseases. | . | Czech Republic. | Charles University in Prague. Faculty of Medicine in Hradec Kralove. | Ver documento. |
Health. | HEALTH-2007-2.2.1-7: Restorative approaches for therapy of neurodegenerative diseases. | . | United Kingdom. | Chimatica Ltd. Drug Design (SME). | Ver documento. |
Health. | HEALTH-2007-2.2.1-7: Restorative approaches for therapy of neurodegenerative diseases. | . | Belgium. | Professor Roland Pochet at: rpochet@ulb.ac.be. | Ver documento. |
Health. | HEALTH-2007-2.2.1-7: Restorative approaches for therapy of neurodegenerative diseases. | . | Luxembourg. | AxoGlia Therapeutics SA. | Ver documento. |
Health. | HEALTH-2007-2.2.1-7: Restorative approaches for therapy of neurodegenerative diseases. | . | Portugal. | ECBio- I&D em Biotecnologia. | Ver documento. |
Health. | HEALTH-2007-2.2.1-8: From mood disorders to experimental models.. | . | Ausria. | University of Vienna. Max F. Perutz Laboratories. |
